3
Announcements
Trials
Browse
Landscape
Phase
Phase 4
1
Status
Terminated
1
Sponsor Class
OTHER
1
Study Type
Interventional
1
Sponsor
Cancer Type
Classical hematology
1
Conditions
Vitamin D Deficiency
4
Neoplasms
3
Precursor Cell Lymphoblastic Leukemia-Lymphoma
2
Polycystic Ovary Syndrome
2
Renal Insufficiency, Chronic
1
Myelodysplastic Syndromes
1
Multiple Sclerosis, Relapsing-Remitting
1
Hepatitis B, Chronic
1
Hepatitis B
1
Hematologic Diseases
1
Cardiovascular Diseases
1
Carcinoma, Transitional Cell
1
Carcinoma, Hepatocellular
1
Bone Diseases, Metabolic
1
Anemia, Aplastic
1
Anemia
1
Interventions
Epoetin Alfa
8
ferric carboxymaltose
6
epoetin beta
6
Darbepoetin alfa
4
ferrous sulfate
2
ferrous fumarate
2
Radiotherapy
2
iron isomaltoside 1000
1
ferrous succinate
1
ferric gluconate
1
Vitamin B 12
1
Thiotepa
1
Standard of Care
1
Hematinics
1
Folic Acid
1
Filgrastim
1
Erythropoietin
1
Cyclophosphamide
1
Cisplatin
1
Cholecalciferol
1
Brachytherapy
1
Antilymphocyte Serum
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Phase 4
×
Anemia
×
Cholecalciferol
×
Clear all
NCT01817699
2019-02-04
CANDLE-KIT
CANDLE-KIT Trial Study Group
Phase 4
Terminated
161 enrolled